Champions Oncology, Inc.
(NASDAQ: CSBR)

Champions Oncology, Inc. is engaged in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The Company has two business segments: Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). The Company's POS business provides services to physicians and patients looking for information to help guide the development of personalized treatment plans. The Company's TOS business provides services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. The Company's TumorGraft Technology Platform consists of processes, physical tumors and information that it uses to personalize the development and use of oncology drugs.

6.180

+0.180 (+3.00%)
Range 6.120 - 6.219   (1.62%)
Open 6.120
Previous Close 6.000
Bid Price 4.630
Bid Volume 8
Ask Price -
Ask Volume 9
Volume 4,828
Value -
Remark
Delayed prices. Updated at 05 Dec 2025 23:05.
Data powered by
View All Events

About Champions Oncology

Champions Oncology, Inc. is engaged in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The Company has two business segments: Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). The Company's POS business provides services to physicians and patients looking for information to help guide the development of personalized treatment plans. The Company's TOS business provides services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. The Company's TumorGraft Technology Platform consists of processes, physical tumors and information that it uses to personalize the development and use of oncology drugs.

Loading Chart...

Please login to view stock data and analysis